Kenmerk
Excessive sweating
Klinische naam: Hyperhidrosis
Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.
Samenvatting
- Ook bekend als
- Increased sweating, Profuse sweating, Sweating, Sweating profusely, Sweating, increased, Diaphoresis
- Lichaamssysteem
- Abnormality of the integument
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Excessive sweating, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen137 genen gekoppeld aan Excessive sweating
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Excessive sweating voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| BOLA3bolA family member 3 | Altijd | In 1 aandoening |
| DSG1desmoglein 1 | Altijd | In 1 aandoening |
| IRF4interferon regulatory factor 4 | Altijd | In 1 aandoening |
| LIFRLIF receptor subunit alpha | Altijd | In 2 aandoeningen |
| MAP2K1mitogen-activated protein kinase kinase 1 | Altijd | In 2 aandoeningen |
| MAP2K2mitogen-activated protein kinase kinase 2 | Altijd | In 2 aandoeningen |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Altijd | In 1 aandoening |
| SLC18A2solute carrier family 18 member A2 | Altijd | In 2 aandoeningen |
| SUCLG1succinate-CoA ligase GDP/ADP-forming subunit alpha | Altijd | In 2 aandoeningen |
| AIPAHR interacting HSP90 co-chaperone | Heel vaak (80–99%) | In 2 aandoeningen |
| AQP5aquaporin 5 | Heel vaak (80–99%) | In 1 aandoening |
| BCL10BCL10 immune signaling adaptor | Heel vaak (80–99%) | In 1 aandoening |
| BIRC3baculoviral IAP repeat containing 3 | Heel vaak (80–99%) | In 1 aandoening |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Heel vaak (80–99%) | In 2 aandoeningen |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Heel vaak (80–99%) | In 1 aandoening |
| CLCF1cardiotrophin like cytokine factor 1 | Heel vaak (80–99%) | In 1 aandoening |
| CRLF1cytokine receptor like factor 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| ELP1elongator acetyltransferase complex subunit 1 | Heel vaak (80–99%) | In 1 aandoening |
| FOXP1forkhead box P1 | Heel vaak (80–99%) | In 1 aandoening |
| FUCA1alpha-L-fucosidase 1 | Heel vaak (80–99%) | In 1 aandoening |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Heel vaak (80–99%) | In 1 aandoening |
| GPR101G protein-coupled receptor 101 | Heel vaak (80–99%) | In 2 aandoeningen |
| HNF4Ahepatocyte nuclear factor 4 alpha | Heel vaak (80–99%) | In 1 aandoening |
| HPGD15-hydroxyprostaglandin dehydrogenase | Heel vaak (80–99%) | In 3 aandoeningen |
| IGHimmunoglobulin heavy locus | Heel vaak (80–99%) | In 1 aandoening |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Heel vaak (80–99%) | In 1 aandoening |
| KIF1Akinesin family member 1A | Heel vaak (80–99%) | In 1 aandoening |
| KRASKRas proto-oncogene, GTPase | Heel vaak (80–99%) | In 1 aandoening |
| MALT1MALT1 paracaspase | Heel vaak (80–99%) | In 1 aandoening |
| MEN1menin 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| NLRP3NLR family pyrin domain containing 3 | Heel vaak (80–99%) | In 1 aandoening |
| PHOX2Bpaired like homeobox 2B | Heel vaak (80–99%) | In 2 aandoeningen |
| RETREG1reticulophagy regulator 1 | Heel vaak (80–99%) | In 1 aandoening |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Heel vaak (80–99%) | In 2 aandoeningen |
| SERPINB7serpin family B member 7 | Heel vaak (80–99%) | In 1 aandoening |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Heel vaak (80–99%) | In 3 aandoeningen |
| WNK1WNK lysine deficient protein kinase 1 | Heel vaak (80–99%) | In 1 aandoening |
| YY1YY1 transcription factor | Heel vaak (80–99%) | In 1 aandoening |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Vaak (30–79%) | In 1 aandoening |
| CDH23cadherin related 23 | Vaak (30–79%) | In 1 aandoening |
Toon nog 97 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| CDKN2Acyclin dependent kinase inhibitor 2A | Vaak (30–79%) | In 1 aandoening |
| CLCN6Cl-/H+ antiporter 6 | Vaak (30–79%) | In 1 aandoening |
| CTC1CST telomere replication complex component 1 | Vaak (30–79%) | In 1 aandoening |
| CTNNB1catenin beta 1 | Vaak (30–79%) | In 1 aandoening |
| CTSHcathepsin H | Vaak (30–79%) | In 1 aandoening |
| DDCdopa decarboxylase | Vaak (30–79%) | In 2 aandoeningen |
| DKC1dyskerin pseudouridine synthase 1 | Vaak (30–79%) | In 2 aandoeningen |
| DSTdystonin | Vaak (30–79%) | In 1 aandoening |
| FGFR2fibroblast growth factor receptor 2 | Vaak (30–79%) | In 2 aandoeningen |
| FLRT1fibronectin leucine rich transmembrane protein 1 | Vaak (30–79%) | In 1 aandoening |
| GNA14G protein subunit alpha 14 | Vaak (30–79%) | In 2 aandoeningen |
| HCRThypocretin neuropeptide precursor | Vaak (30–79%) | In 1 aandoening |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Vaak (30–79%) | In 1 aandoening |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Vaak (30–79%) | In 2 aandoeningen |
| JAK2Janus kinase 2 | Vaak (30–79%) | In 1 aandoening |
| JUPjunction plakoglobin | Vaak (30–79%) | In 1 aandoening |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Vaak (30–79%) | In 1 aandoening |
| KLC2kinesin light chain 2 | Vaak (30–79%) | In 2 aandoeningen |
| MOGmyelin oligodendrocyte glycoprotein | Vaak (30–79%) | In 1 aandoening |
| MPLMPL proto-oncogene, thrombopoietin receptor | Vaak (30–79%) | In 1 aandoening |
| NGLY1N-glycanase 1 | Vaak (30–79%) | In 1 aandoening |
| NHP2NHP2 ribonucleoprotein | Vaak (30–79%) | In 1 aandoening |
| NOP10NOP10 ribonucleoprotein | Vaak (30–79%) | In 1 aandoening |
| NPM1nucleophosmin 1 | Vaak (30–79%) | In 1 aandoening |
| P2RY11purinergic receptor P2Y11 | Vaak (30–79%) | In 1 aandoening |
| PARNpoly(A)-specific ribonuclease | Vaak (30–79%) | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Vaak (30–79%) | In 1 aandoening |
| PRNPprion protein (Kanno blood group) | Vaak (30–79%) | In 2 aandoeningen |
| RTEL1regulator of telomere elongation helicase 1 | Vaak (30–79%) | In 1 aandoening |
| SLC16A2solute carrier family 16 member 2 | Vaak (30–79%) | In 1 aandoening |
| SLURP1secreted LY6/PLAUR domain containing 1 | Vaak (30–79%) | In 2 aandoeningen |
| SPRsepiapterin reductase | Vaak (30–79%) | In 1 aandoening |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Vaak (30–79%) | In 1 aandoening |
| TATtyrosine aminotransferase | Vaak (30–79%) | In 1 aandoening |
| TERCtelomerase RNA component | Vaak (30–79%) | In 1 aandoening |
| TERTtelomerase reverse transcriptase | Vaak (30–79%) | In 2 aandoeningen |
| THPOthrombopoietin | Vaak (30–79%) | In 1 aandoening |
| TINF2TERF1 interacting nuclear factor 2 | Vaak (30–79%) | In 1 aandoening |
| TNFSF4TNF superfamily member 4 | Vaak (30–79%) | In 1 aandoening |
| TP53tumor protein p53 | Vaak (30–79%) | In 1 aandoening |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Vaak (30–79%) | In 1 aandoening |
| TYMSthymidylate synthetase | Vaak (30–79%) | In 1 aandoening |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Vaak (30–79%) | In 1 aandoening |
| WRAP53WD repeat containing antisense to TP53 | Vaak (30–79%) | In 1 aandoening |
| ZNF365zinc finger protein 365 | Vaak (30–79%) | In 1 aandoening |
| ZNRF3zinc and ring finger 3 | Vaak (30–79%) | In 1 aandoening |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Soms (5–29%) | In 1 aandoening |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Soms (5–29%) | In 1 aandoening |
| CCND1cyclin D1 | Soms (5–29%) | In 1 aandoening |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Soms (5–29%) | In 1 aandoening |
| COL17A1collagen type XVII alpha 1 chain | Soms (5–29%) | In 1 aandoening |
| CTSBcathepsin B | Soms (5–29%) | In 1 aandoening |
| CUL4Bcullin 4B | Soms (5–29%) | In 1 aandoening |
| FBXO11F-box protein 11 | Soms (5–29%) | In 1 aandoening |
| GRB10growth factor receptor bound protein 10 | Soms (5–29%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Soms (5–29%) | In 1 aandoening |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Soms (5–29%) | In 2 aandoeningen |
| KRT1keratin 1 | Soms (5–29%) | In 1 aandoening |
| KRT14keratin 14 | Soms (5–29%) | In 1 aandoening |
| KRT16keratin 16 | Soms (5–29%) | In 1 aandoening |
| KRT5keratin 5 | Soms (5–29%) | In 1 aandoening |
| KRT9keratin 9 | Soms (5–29%) | In 1 aandoening |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Soms (5–29%) | In 1 aandoening |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Soms (5–29%) | In 1 aandoening |
| PLAAphospholipase A2 activating protein | Soms (5–29%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Soms (5–29%) | In 1 aandoening |
| RHOBTB2Rho related BTB domain containing 2 | Soms (5–29%) | In 1 aandoening |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Soms (5–29%) | In 1 aandoening |
| SLC1A3solute carrier family 1 member 3 | Soms (5–29%) | In 1 aandoening |
| SLC2A1solute carrier family 2 member 1 | Soms (5–29%) | In 1 aandoening |
| SLC39A14solute carrier family 39 member 14 | Soms (5–29%) | In 1 aandoening |
| SPRED2sprouty related EVH1 domain containing 2 | Soms (5–29%) | In 1 aandoening |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Soms (5–29%) | In 1 aandoening |
| VHLvon Hippel-Lindau tumor suppressor | Soms (5–29%) | In 2 aandoeningen |
| WNT10AWnt family member 10A | Soms (5–29%) | In 1 aandoening |
| CLCNKBchloride voltage-gated channel Kb | Zelden (1–4%) | In 1 aandoening |
| GLAgalactosidase alpha | Zelden (1–4%) | In 1 aandoening |
| H19H19 imprinted maternally expressed transcript | Zelden (1–4%) | In 1 aandoening |
| HINT1histidine triad nucleotide binding protein 1 | Zelden (1–4%) | In 2 aandoeningen |
| HMBShydroxymethylbilane synthase | Zelden (1–4%) | In 1 aandoening |
| HRASHRas proto-oncogene, GTPase | Zelden (1–4%) | In 1 aandoening |
| IGF2insulin like growth factor 2 | Zelden (1–4%) | In 1 aandoening |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Zelden (1–4%) | In 1 aandoening |
| SLC12A3solute carrier family 12 member 3 | Zelden (1–4%) | In 1 aandoening |
| COL6A1collagen type VI alpha 1 chain | Niet vastgelegd | In 1 aandoening |
| HEXBhexosaminidase subunit beta | Niet vastgelegd | In 1 aandoening |
| IGHMBP2immunoglobulin mu DNA binding protein 2 | Niet vastgelegd | In 1 aandoening |
| KIF1Bkinesin family member 1B | Niet vastgelegd | In 1 aandoening |
| KRT6Akeratin 6A | Niet vastgelegd | In 1 aandoening |
| MAXMYC associated transcriptional regulator X | Niet vastgelegd | In 1 aandoening |
| RETret proto-oncogene | Niet vastgelegd | In 1 aandoening |
| SCN11Asodium voltage-gated channel alpha subunit 11 | Niet vastgelegd | In 1 aandoening |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Niet vastgelegd | In 1 aandoening |
| SDHCsuccinate dehydrogenase complex subunit C | Niet vastgelegd | In 1 aandoening |
| SDHDsuccinate dehydrogenase complex subunit D | Niet vastgelegd | In 1 aandoening |
| TMEM127transmembrane protein 127 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken